Ms. Ameera Shah

Ms. Ameera Shah is the Promoter and Managing Director of Metropolis Healthcare Limited. A global thought leader in the healthcare industry, she has played an instrumental role in changing the pathology industry landscape in the country; from being a doctor led practice to a professional corporate group in an extremely unregulated, competitive, and fragmented market.

Over the two decades, Ms. Shah has built the organization across the board, and has been a dynamic driving force behind the entire corporate transformation and the sustained growth of Metropolis. Due to its unique growth model and competitive advantage, Metropolis has attracted three rounds of investment by reputed private equity investors. Under the leadership of Ms. Shah, Metropolis listed successfully at the stock exchanges in 2019 and within three years of its listing, the company cemented a position of trust with international and domestic investors by posting industry leading performance every quarter and delivering good returns on their investments. Upholding the highest standards of corporate governance and business ethics, Metropolis has built exceptional value for all its stakeholders.

Ms. Ameera Shah is the recipient of the ‘Entrepreneur of the Year’ Award in healthcare category for the year 2021 from Ernst & Young. She has been named amongst ‘Asia’s Power Businesswoman’ (2020) by Forbes Asia, ‘Fifty Most Powerful Women in Business’ by Fortune India (2017, 2018, 2019, 2020, 2021) and Business Today (2018, 2019, 2021, 2022). She has been bestowed with multiple awards for her outstanding performance & excellence in diagnostics business and entrepreneurship from various reputed organizations.

Ms. Ameera Shah is an eminent industry spokesperson and has been a speaker in various National and International forums, industry events and conclaves. She has been an active member & has served senior level positions in key industry bodies that drives policy decisions at the Center. She is currently serving as the Sr. Vice-President of NATHealth (Healthcare Federation of India).

Ms. Shah is an independent director on the board of reputed Indian companies (Torrent Pharma, Adani Group). Prior to the Pandemic, she was an advisor to Baylor College of Medicine, Texas and the global advisory board of AXA, a Paris headquartered company with 700 billion$ under asset management.